Biotech & MedTech
-
Hugh Rogers on the European approval of the XPhyto Therapeutics point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system
In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE:…
-
Sixth Wave Innovations Dr Jon Gluckman on the colorimetric detection of SARS-CoV-2
In a recent InvestorIntel interview, Tracy Weslosky spoke with Dr. Jon Gluckman, President, CEO and Founder of Sixth…
-
StageZero’s New Cancer-Testing Platform and Health Clinics Acquisition Forms Telemedicine “Circle of Care”
StageZero Life Sciences Ltd. (TSX: SZLS) is a life science and telehealth company that recently launched Aristotle®, which…
-
Valeo Pharma launches Redesca™ and is forecasting company revenues to increase 20x by 2025
Bringing new pharmaceutical products to market is a long and expensive process. One Canadian company has found an…
-
Thomas Smeenk on Hemostemix’s autologous stem cell therapy technology and why some call it ‘the fountain of youth’
In a recent InvestorIntel interview, Tracy Weslosky spoke with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc.…
-
Mental health at the forefront of new research into Psychedelics
The liberalization of cannabis usage (pun intended) has made strides in opening up other aspects of the drug…
-
Will Sixth Wave help prevent a fourth wave?
Sixth Wave Innovations Inc. (CSE: SIXW | OTCQB: ATURF) is a nanotechnology company focused on extraction and detection…
-
Predictiv AI – Using Artificial Intelligence to Solve “Real World” Problems
Predictiv AI’s ThermalPass Part of a Back-to-Work Strategy The U.S. Centers for Disease Control and Prevention (CDC) reported…
-
StageZero Life Sciences James Howard-Tripp on the recent LOI to Acquire Health Clinics Limited
In a recent InvestorIntel interview, Tracy Weslosky spoke with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
